nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.587	1	CbGbCtD
Efavirenz—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0303	CcSEcCtD
Efavirenz—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0286	CcSEcCtD
Efavirenz—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.011	0.0266	CcSEcCtD
Efavirenz—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00821	0.0199	CcSEcCtD
Efavirenz—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00793	0.0192	CcSEcCtD
Efavirenz—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00775	0.0188	CcSEcCtD
Efavirenz—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00711	0.0172	CcSEcCtD
Efavirenz—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00684	0.0166	CcSEcCtD
Efavirenz—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00665	0.0161	CcSEcCtD
Efavirenz—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00659	0.016	CcSEcCtD
Efavirenz—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0158	CcSEcCtD
Efavirenz—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00647	0.0157	CcSEcCtD
Efavirenz—Mania—Riluzole—amyotrophic lateral sclerosis	0.00641	0.0155	CcSEcCtD
Efavirenz—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00624	0.0151	CcSEcCtD
Efavirenz—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00624	0.0151	CcSEcCtD
Efavirenz—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00619	0.015	CcSEcCtD
Efavirenz—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.0058	0.014	CcSEcCtD
Efavirenz—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00575	0.0139	CcSEcCtD
Efavirenz—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00562	0.0136	CcSEcCtD
Efavirenz—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.0055	0.0133	CcSEcCtD
Efavirenz—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00542	0.0131	CcSEcCtD
Efavirenz—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00509	0.0123	CcSEcCtD
Efavirenz—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00509	0.0123	CcSEcCtD
Efavirenz—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00493	0.0119	CcSEcCtD
Efavirenz—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00493	0.0119	CcSEcCtD
Efavirenz—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00493	0.0119	CcSEcCtD
Efavirenz—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00475	0.0115	CcSEcCtD
Efavirenz—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00461	0.0112	CcSEcCtD
Efavirenz—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0045	0.0109	CcSEcCtD
Efavirenz—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00405	0.0098	CcSEcCtD
Efavirenz—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00401	0.0097	CcSEcCtD
Efavirenz—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00912	CcSEcCtD
Efavirenz—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00904	CcSEcCtD
Efavirenz—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00872	CcSEcCtD
Efavirenz—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00869	CcSEcCtD
Efavirenz—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00338	0.0082	CcSEcCtD
Efavirenz—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00807	CcSEcCtD
Efavirenz—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00807	CcSEcCtD
Efavirenz—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00801	CcSEcCtD
Efavirenz—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00776	CcSEcCtD
Efavirenz—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00771	CcSEcCtD
Efavirenz—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00746	CcSEcCtD
Efavirenz—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00741	CcSEcCtD
Efavirenz—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00723	CcSEcCtD
Efavirenz—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00713	CcSEcCtD
Efavirenz—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00708	CcSEcCtD
Efavirenz—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00695	CcSEcCtD
Efavirenz—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00673	CcSEcCtD
Efavirenz—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00647	CcSEcCtD
Efavirenz—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00635	CcSEcCtD
Efavirenz—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00632	CcSEcCtD
Efavirenz—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00632	CcSEcCtD
Efavirenz—Depression—Riluzole—amyotrophic lateral sclerosis	0.0026	0.0063	CcSEcCtD
Efavirenz—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00619	CcSEcCtD
Efavirenz—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00616	CcSEcCtD
Efavirenz—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00606	CcSEcCtD
Efavirenz—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00602	CcSEcCtD
Efavirenz—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00597	CcSEcCtD
Efavirenz—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00593	CcSEcCtD
Efavirenz—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00568	CcSEcCtD
Efavirenz—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00567	CcSEcCtD
Efavirenz—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00564	CcSEcCtD
Efavirenz—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00564	CcSEcCtD
Efavirenz—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0056	CcSEcCtD
Efavirenz—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00559	CcSEcCtD
Efavirenz—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00557	CcSEcCtD
Efavirenz—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00556	CcSEcCtD
Efavirenz—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00536	CcSEcCtD
Efavirenz—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0053	CcSEcCtD
Efavirenz—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00526	CcSEcCtD
Efavirenz—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00514	CcSEcCtD
Efavirenz—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00512	CcSEcCtD
Efavirenz—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00511	CcSEcCtD
Efavirenz—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00507	CcSEcCtD
Efavirenz—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00501	CcSEcCtD
Efavirenz—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00494	CcSEcCtD
Efavirenz—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00486	CcSEcCtD
Efavirenz—Tension—Riluzole—amyotrophic lateral sclerosis	0.002	0.00484	CcSEcCtD
Efavirenz—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.002	0.00483	CcSEcCtD
Efavirenz—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00479	CcSEcCtD
Efavirenz—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00477	CcSEcCtD
Efavirenz—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00462	CcSEcCtD
Efavirenz—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00458	CcSEcCtD
Efavirenz—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00456	CcSEcCtD
Efavirenz—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00454	CcSEcCtD
Efavirenz—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00451	CcSEcCtD
Efavirenz—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00445	CcSEcCtD
Efavirenz—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00443	CcSEcCtD
Efavirenz—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00443	CcSEcCtD
Efavirenz—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00436	CcSEcCtD
Efavirenz—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00434	CcSEcCtD
Efavirenz—Cough—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00431	CcSEcCtD
Efavirenz—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00428	CcSEcCtD
Efavirenz—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00426	CcSEcCtD
Efavirenz—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0042	CcSEcCtD
Efavirenz—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0042	CcSEcCtD
Efavirenz—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0042	CcSEcCtD
Efavirenz—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00419	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00417	CcSEcCtD
Efavirenz—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00415	CcSEcCtD
Efavirenz—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00411	CcSEcCtD
Efavirenz—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00406	CcSEcCtD
Efavirenz—Shock—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00396	CcSEcCtD
Efavirenz—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00395	CcSEcCtD
Efavirenz—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00394	CcSEcCtD
Efavirenz—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00393	CcSEcCtD
Efavirenz—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00391	CcSEcCtD
Efavirenz—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00389	CcSEcCtD
Efavirenz—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00384	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00367	CcSEcCtD
Efavirenz—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00364	CcSEcCtD
Efavirenz—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00362	CcSEcCtD
Efavirenz—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00359	CcSEcCtD
Efavirenz—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00358	CcSEcCtD
Efavirenz—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00355	CcSEcCtD
Efavirenz—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0035	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00348	CcSEcCtD
Efavirenz—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00347	CcSEcCtD
Efavirenz—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00345	CcSEcCtD
Efavirenz—Pain—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00345	CcSEcCtD
Efavirenz—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00332	CcSEcCtD
Efavirenz—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00329	CcSEcCtD
Efavirenz—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0032	CcSEcCtD
Efavirenz—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00318	CcSEcCtD
Efavirenz—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00318	CcSEcCtD
Efavirenz—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00297	CcSEcCtD
Efavirenz—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00289	CcSEcCtD
Efavirenz—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00285	CcSEcCtD
Efavirenz—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00276	CcSEcCtD
Efavirenz—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00266	CcSEcCtD
Efavirenz—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00256	CcSEcCtD
Efavirenz—Rash—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00254	CcSEcCtD
Efavirenz—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00254	CcSEcCtD
Efavirenz—Headache—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00252	CcSEcCtD
Efavirenz—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000988	0.00239	CcSEcCtD
